Using virtual tools to help veterans join heart research
Part of Heart & circulation clinical trials.
This study looks at better ways to invite veterans to join heart research using online tools. By taking part, you can help make future heart studies easier for veterans to learn about and join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a veteran who has been invited to join a VA heart study.
- You receive care at the Palo Alto VA or another VA research site.
- You can watch a short video and fill out a survey in English.
- You haven't been excluded from the main heart study for any reason.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if virtual coaching can help more veterans attend cardiac rehabilitation at home. It is for veterans with heart conditions who have been referred to home-based cardiac rehab.
This trial tests an AI-guided approach to treating atrial fibrillation (AF), a heart rhythm problem. It aims to personalize your treatment plan to better manage symptoms and improve outcomes.
This study tests a chatbot that asks you about your health after a heart procedure called ablation, which treats an irregular heartbeat (atrial fibrillation). It aims to make follow-up easier and help you recover better.
This trial uses an artificial intelligence tool to read your heart's electrical signals and check how well your heart is recovering after a procedure to fix an irregular heartbeat called atrial fibrillation. It aims to find early signs of heart failure and guide better care.
This study looks at ways to help heart rhythm doctors who work in certain VA regions choose better heart devices (like pacemakers and defibrillators) for their patients. If you are a VA doctor who implants these devices, you may be able to help improve how they are selected.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.